|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/62 | |
| A61K 38/46 | |||
| C12N 9/16 | |||
| A61P 19/08 |
| (11) | Number of the document | 2348114 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11000196.3 |
| Date of filing the European patent application | 2005-04-21 | |
| (97) | Date of publication of the European application | 2011-07-27 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 563828 P | 2004-04-21 | US | |
| 590347 P | 2004-07-23 | US | |
| 614984 P | 2004-10-04 | US |
| (72) |
Crine, Philippe, CA
Boileau, Guy, CA
Lemire, Isabelle, CA
Loisel, Thomas P., CA
|
| (73) |
Alexion Pharmaceuticals, Inc.,
100 College Street, New Haven, CT 06510,
US
|
| (54) | Bone delivery conjugates and method of using same to target proteins to bone |
| Bone delivery conjugates and method of using same to target proteins to bone |